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2) Many compounds related to lipid A partial structures have been synthesized with the aim of enhancing biological activities. 3) In a series of structure-activity relationship studies on lipid A, we have already reported the synthesis and biological activities of N-acylated L-serine, -containing D-glucosamine derivatives structurally similar to the lipid A disaccharide backbone. As a result, it was found that the mitogenic activity of N-tetradecanoyl L-serine-linked lipid A analog (2) is stronger than that of L-threonine and L-homoserine linked lipid A analogs and the phosphate group was not required in lipid A analogs for mitogenicity.
Recently, the development of totally synthetic vaccines against cancers or human immunodeficiency virus (HIV) using a synthetic immunoadjuvant, such as N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) and lipopeptide analogs, have been attempted. 5) We plan to develop completely synthetic vaccines which consist of a lipid A analog, covalently coupled to a low-molecular-weight antigen. With the aim of determining favorable binding linkages of lipid A analog (3, 5) to an antigen moiety, we designed new non-reducing N-acylated L-serine-containing D-glucosamine derivatives (Type A, B, C) (Fig. 2) . In this paper, we describe the synthesis and mitogenic activity of new N-acylated L-serinecontaining D-glucosamine analogs (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) 30) in comparison with that of synthetic phosphorylated lipid A analog (1) 6) and bacterial LPS.
Synthesis First, we planned to introduce Boc-L-glycine as a spacer to the nitrogen group of the L-serine residue for 6 or 7 as Type A. Compounds 6 and 7 were synthesized from compound 16 as a starting material according to the routes shown in Charts 1 and 2, respectively. Glycosidation of 16 with 17 using N-bromosuccinimide (NBS), I 2 , n-tetrabutylammonium trifluoromethanesulfonate (TBAOTf ) as a promoter, and molecular sieves 4A°in CH 2 Cl 2 gave the b-glycoside (18) in 49% yield. The b-configuration of 18 was confirmed by NMR spectroscopy; the 13 C-NMR showed the C-1 signal as a doublet at d 102.5 (Jϭ160. 6 Hz) . 7) Removal of the 2,2,2-trichloroethoxycarbonyl (Troc) group of 18 with activated Zn powder in acetic acid (AcOH), followed by acylation using (R)-3-(tetradecanoyloxy)tetradecanoic acid (C 14 OC 14 OH) in the presence of diethyl phosphorocyanidate (DEPC) and triethylamine (NEt 3 ) in CH 2 Cl 2 afforded 19 in 81% yield in two steps. Finally, hydrogenolysis of the benzyl group using Pd-black as a catalyst in tetrahydrofuran (THF) gave the desired product 6 in 67% yield ϩ , 1009 (MϩNa) ϩ ]. Synthesis of compound 7 was carried out as follows. Glycosidation of 20 with 17 in the presence of HgBr 2 and molecular sieves 4A°in CH 2 Cl 2 gave b-glycoside (21) in 61% yield. The b-configuration of 21 was confirmed by NMR spectroscopy; the 1 H-NMR showed the H-1 signal as a doublet at d 4.32 (Jϭ8. 9 Hz) . In the same way, after removal of the Troc group of 21 with activated Zn powder in AcOH, subsequent N-acylation with C 14 OC 14 OH in the presence of dicyclohexylcarbodiimide (DCC) in CH 2 Cl 2 afforded 22 in 22% yield in two steps. Acylation of the remaining hydroxyl group of 22 with tetradecanoic acid (C 14 OH) in the presence of DCC-N,N-dimethylaminopyridine (DMAP) in CH 2 Cl 2 Removal of the Troc group of 25 with activated Zn dust in AcOH, followed by N-acylation with C 14 OC 14 OH in the presence of DCC and 1-hydroxybenzotriazole (HOBt) in CH 2 Cl 2 -THF afforded 26 in 78% yield in two steps. Hydrogenolysis of the benzyl group of 26 using Pd-black as a catalyst in MeOH-THF gave 27 in 79% yield. The treatment of 27 with b-alanine benzyl ester, L-alanine benzyl ester, Dalanine benzyl ester, glycine benzyl ester or 2-benzyloxycarbonylaminoethylamine (EDA-Z) using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (WSC · HCl), HOBt and N-methylmorpholine (NMM) in N,N-dimethylformamide (DMF) gave 28a-e in 75, 66, 62, 75 and 68% yields, respectively. Hydrogenolysis of 28a-d using Pdblack as a catalyst in THF gave 29a-d in 98, 94, 88 and 94% yields, respectively. Finally, deprotection of the acetyl groups of 29a-d with conc. NH 4 OH in MeOH-THF afforded 8-11 in 74, 32, 75 and 62% yields, respectively. Compound 12 was also prepared by the treatment of 28e with conc. NH 4 OH in MeOH-THF in 59% yield.
For the preparation of compound 13, the starting compound 31 was treated with tetradecanoyl chloride (C 14 Cl) in the presence of DMAP and pyridine in CH 2 Cl 2 to give 32 in 96% yield. After the treatment of 32 with 90% AcOH at room temperature, acetylation of the corresponding diol with Ac 2 O-pyridine provided 33 in 93% yield. Glycosidation of 33 with 24 using NBS, I 2 In order to synthesize a series of compounds for Type C, we used compounds 14 and 15 possessing an amino group in place of a hydroxyl group at the C-6 of D-glucosamine, then the selective tosylation of 6-OH of 39 was carried out with ptoluenesulfonyl chloride in pyridine-CH 2 Cl 2 , and acetylation of the corresponding tosylate with acetic anhydride in pyridine furnished acetate 40 in 75% in two steps. Subsequently, treatment of the tosylate 40 with sodium azide (NaN 3 ), 18-crown-6 in DMF gave 6- Figs. 3-5, compound 8 for Type B showed the most potent mitogenicity among the analogs tested at 12.5 mM. Furthermore, the lethal toxicity of 8 in D-galactosamine-loaded C57BL/6 mice 9) was much lower than that of natural LPS. However, compounds 6 and 7 for Type A, and 14 and 15 for Type C, exhibited weaker mitogenicity than that of the lipid A analog 1 as a non-reducing unit of lipid A.
In conclusion, among these new N-acylated L-serine-containing D-glucosamine analogs (Type A, B, C), compound 8 for Type B exhibited the most potent mitogenicity. The mitogenicity of D-alanine derivative 10 was higher than that of Lalanine derivative 9, suggesting that the configuration of the alanine part of 9 and 10 as a spacer affects the expression of biological activity. The reason compound 8 showed potent mitogenicity in comparison with 9 and 10 is unclear, but the difference in carbon chain length between the b-alanine residue and the L or D-alanine residue may affect the potency.
Further, the application of compound 8 as a synthetic immunoadjuvant to synthetic vaccines is in progress.
Experimental
All melting points are uncorrected. Optical rotations were measured with a JASCO DIP-140 digital polarimeter. IR spectra were recorded on a JASCO A-202 infrared spectrophotometer. FAB-MS were recorded on a JEOL JMS- 3 OD as an internal standard. The abbreviations of signal patterns are as follows: s, singlet; br s, broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet. Column chromatography was carried out on Silica gel 60 (70-230 mesh, Merck). Thinlayer chromatography (TLC) on Silica gel 60-F 254 (Merck) was used to monitor the reaction and to ascertain the purity of the reaction products. The spots were visualized by spraying the plates with 5% aqueous sulfuric acid, followed by heating.
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N-(tert-Butoxycarbonyl)-glycyl-O-[3,4,6-tri-O-acetyl-2-deoxy-2-[(R)-3-tetradecanoyloxytetradecanoylamino]-b b -D-glucopyranosyl]-L-serine Benzyl Ester (19)
A mixture of 18 (140 mg, 0.172 mmol) and activated zinc powder (750 mg) in AcOH (2 ml) was stirred for 20 h at 40-50°C. The precipitate was filtered off and the filtrate was diluted with CH 2 Cl 2 , washed with 10% aqueous NaHCO 3 and brine, dried over anhydrous MgSO 4 , and concentrated under reduced pressure. The residue and (R)-3-tetradecanoyloxytetradecanoic acid (72 mg, 0.16 mmol) was dissolved in DMF (2 ml), and to the mixture, DEPC (26 mg, 0.16 mmol) and NEt 3 (16 mg, 0.16 mmol) were added at 0°C under argon. The reaction mixture was stirred at the same temperature for 1 h, then at room temperature for 10 h. It was then diluted with CH 2 Cl 2 , washed with 10% aqueous NaHCO 3 and brine, dried over anhydrous MgSO 4 , and concentrated under reduced pressure. 
N-(tert-Butoxycarbonyl)-glycyl-O-[3, 4, 6-tri-O-acetyl-2-deoxy-2-[(R)-
Benzyl Ester (21) HgBr 2 (62 mg, 0.173 mmol) was added to a stirred mixture of 20 (245 mg, 0.345 mmol), 17 (122 mg, 0.345 mmol) and MS 4A°(800 mg) in dry CH 2 Cl 2 (6 ml) at 0°C under argon and the whole was stirred at the same temperature for 1 h. After stirring for 20 h at room temperature, the suspension was filtered off and the filtrate was diluted with CH 2 Cl 2 and then washed with 10% KI and brine, dried over anhydrous MgSO 4 , and concentrated under reduced pressure. The residue was chromatographed on a silica gel column (hexane : AcOEtϭ2 : 1) 
N-(tert-Butoxycarbonyl)-glycyl-O-[4,6-di-O-benzyl-2-deoxy-2-[(R)-3-tetradecanoyloxytetradecanoylamino]-b b -D-glucopyranosyl]-L-serine Benzyl Ester (22)
In a manner similar to that for the synthesis of 19, 21 (124 mg, 0.12 mmol) was deprotected and acylated with (R)-3-tetradecanoyl- 
N-(tert-Butoxycarbonyl)-glycyl-O-[2-deoxy-3-O-tetradecanoyl-2-[(R)-
Compound 23 (24 mg, 0.018 mmol) was treated in the same manner as described above to obtain 10 mg (53%) of 7 
N-Tetradecanoyl-O-[3,4,6-tri-O-acetyl-2-deoxy-2-[(R)-3-tetradecanoyloxy-tetradecanoylamino]-b b-D-glucopyranosyl]-L-seryl-b b-alanine Benzyl
Ester (28a) WSC · HCl (46 mg, 0.24 mmol) and N-methylmorpholine (24 mg, 0.24 mmol) was added to a stirred mixture of 27 (165 mg, 0.16 mmol), b-alanine benzyl ester p-TsOH (84 mg, 0.24 mmol) and HOBt (37 mg, 0.24 mmol) in DMF (6 ml) at 0°C under argon. The reaction mixture was stirred at the same temperature for 1 h, then at room temperature for 20 h. The suspension was filtered off and the filtrate was concentarated under reduced pressure. It was then diluted with AcOEt, washed with 10% aqueous NaHCO 3 and brine, dried over anhydrous MgSO 4 and concentrated under reduced pressure. The residue was chromatographed on a silica gel column (hexane : AcOEtϭ1 : 1) 
N-Tetradecanoyl-O-[3,4,6-tri-O-acetyl-2-deoxy-2-[(R)-3-tetradecanoyl-
A mixture of 28a (110 mg, 0.092 mmol) and palladium-black (70 mg) in THF (7 ml) was hydrogenated at 40-50°C. The catalyst was filtered off and the filtrate was concentrated under reduced pressure. (3.95 g, 16 mmol ) was added to a stirred mixture of 31 (5.65 g, 10.0 mmol) and DMAP (489 mg, 4.0 mmol) in pyridine-CH 2 Cl 2 (2 : 1) (90 ml) at 0°C under argon, and the whole was stirred at room temperature for 10 h. The reaction mixture was diluted with CH 2 Cl 2 , then washed with H 2 O, saturated aqueous NaHCO 3 and brine, dried over anhydrous MgSO 4 , and concentrated under reduced pressure. The residue was chromatographed on a silica gel column (hexane : AcOEtϭ3 : 1) to give 32 (7.47 m, m, 4, 6), 3.76 (3H, s, OCH 3 ), 4.32 (1H, dd, Jϭ4.9, 10.6 Hz, 4.74, 4.83 (each 1H, d, Jϭ11. m, Ph) . (1.37 g, 1.76 mmol) and 90% AcOH (50 ml) was stirred at room temperature for 10 h. The reaction mixture was concentrated under reduced pressure and the residue was chromatographed on a silica gel column (hexane : AcOEtϭ1 : 1) to give the diol (1.13 g, 98%) , which was dissolved in pyridine (6 ml) , and to the mixture was added Ac 2 O (1.87 g, 1.8.3 mmol) m, 5), m, 4.75, 4.80 (each 1H, d, Jϭ11.9 Hz, CH 2 CCl 3 ), 4.84 (1H, d, Jϭ10.6 Hz, 5.03 (1H, t, Jϭ9.6 Hz, 5.32 (1H, t, Jϭ9.6 Hz, 5.63 (1H, d, Jϭ9.6 Hz, NH), m, Ph) . m, m, 5), 3.89 (1H, dd, Jϭ2.3, 9.9 Hz, OCH 2 CHNH), m, m, 6.75 (1H, d, Jϭ7.9 Hz, NH), 7.35 (5H, s, Ph) . WSC · HCl (25 mg, 0.13 mmol) and Nmethylmorpholine (13 mg, 0.13 mmol) were added to a stirred mixture of 36 (120 mg, 0.099 mmol), b-alanine benzyl ester p-TsOH (46 mg, 0.13 mmol), N-methylmorpholine (13 mg, 0.13 mmol) and HOBt (20 mg, 0.13 mmol) in DMF (6 ml) at 0°C under argon. The reaction mixture was stirred at the same temperature for 1 h, then at room temperature for 18 h. The reaction mixture was poured into ice-cooled water and extracted with AcOEt and the organic layer was washed with brine, dried over anhydrous MgSO 4 and concentrated under reduced pressure. -O-[4,6-di-O-acetyl-2-deoxy-3-O-tetradecanoyl-2-[(R)-3-tetradecanoyloxytetradecanoylamino]-b b -D-glucopyranosyl] -Lseryl-b b-alanine (38) A mixture of 37 (100 mg, 0.073 mmol) and palladium-black (100 mg) in THF (7 ml) was hydrogenated at room temperature. The catalyst was filtered off and the filtrate was concentrated under reduced pressure. The residue was chromatographed on a silica gel column (CH 2 (9.68 g, 50.8 mmol) in CH 2 Cl 2 (50 ml) was added to a stirred mixture of 39 (10.0 g, 28.2 mmol) in pyridine (25 ml) at 0°C. After stirring at room temperature for 2 h, Ac 2 O (43.2 g, 423 mmol) was added to the reaction mixture at 0°C and the whole was stirred at room temperature for 5 h and concentarated under reduced pressure. The residue was chromatographed on a silica gel column (hexane : AcOEtϭ2 : 1) to give 40 (13.5 g, 75% 7.35 (2H, d, Jϭ7.9 Hz, Ts), 7.76 (2H, d, Jϭ8.3 Hz, Ts) . (2.11 g, 4.55 mmol) and PhSH (598 mg, 5.92 mmol) in CH 2 Cl 2 (25 ml) at 0°C under argon and the mixture was stirred at room temperature for 24 h. The reaction mixture was washed with saturated aqueous NaHCO 3 and brine, dried over anhydrous MgSO 4 , and concentrated under reduced pressure. The residue was chromatographed on a silica gel column (hexane : AcOEtϭ4 : 1) to give 42 (1.43 g, 61%) . IR (neat): 2100, 1745 cm
N-Tetradecanoyl-O-[2-deoxy-2-[(R)-3-tetradecanoyloxytetradecanoyl-
amino]-b b-D-glucopyranosyl]-L-seryl-b b-alanine (8) AN-Tetradecanoyl-O-[4,6-di-O-acetyl-2-deoxy-3-O-tetradecanoyl-2- (2,2,2-trichloroethoxycarbonylamino)-b b-D-glucopyranosyl]-L-serineN-Tetradecanoyl-O-[4,6-di-O-acetyl-2-deoxy-3-O-tetradecanoyl-2- [(R)-3-tetradecanoyloxytetradecanoylamino]-b b-D-glucopyranosyl]-L-ser- ine (36) A
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